CCL21 and CCL19 expressed in several stromal cells [36] may exhibit antitumor activities at primary tumor sites because these chemokines induce the recruitment of CCR7-expressing activated dendritic cells to the tumor site [2,3,5,37]. Here, CCR7 is linked to neoplasm.